Newleos Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$93.5M

Newleos Therapeutics is a clinical-stage neuroscience company developing therapies for neuropsychiatric disorders, including anxiety and cognitive impairments, with a focus on first-in-class and best-in-class treatments.